Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.

BACKGROUND AND AIMS There is a significant relationship between inheritance of high transforming growth factor (TGF)-beta1 and angiotensinogen-producing genotypes and the development of progressive hepatic fibrosis in patients with chronic hepatitis C. In cardiac and renal fibrosis, TGF-beta1 production may be enhanced by angiotensin II, the principal effector molecule of the renin-angiotensin system. The aim of the present study was to determine the effects of the angiotensin-converting enzyme inhibitor, captopril, on the progression of hepatic fibrosis in the rat bile duct ligation model. METHODS Rats were treated with captopril (100 mg. kg(-1). day(-1)) commencing 1 or 2 weeks after bile duct ligation. Animals with bile duct ligation only and sham-operated animals served as controls. Four weeks after bile duct ligation, indices of fibrosis were assessed. RESULTS Captopril treatment significantly reduced hepatic hydroxyproline levels, mean fibrosis score, steady state messenger RNA levels of TGF-beta1 and procollagen alpha1(I), and matrix metalloproteinase 2 and 9 activity. CONCLUSIONS Captopril significantly attenuates the progression of hepatic fibrosis in the rat bile duct ligation model, and its effectiveness should be studied in human chronic liver diseases associated with progressive fibrosis.

[1]  W. Secor,et al.  Schistosoma mansoni: relationship of tumor necrosis factor-alpha to morbidity and collagen deposition in chronic experimental infection. , 1996, Experimental parasitology.

[2]  A. Gown,et al.  Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. , 1991, The Journal of clinical investigation.

[3]  P. Muriel.  Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat. , 1996, Journal of hepatology.

[4]  A. Evan,et al.  Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. , 1995, The American journal of physiology.

[5]  V. Petrov,et al.  Antagonism of the renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. , 1999, Methods and findings in experimental and clinical pharmacology.

[6]  W. Border,et al.  Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? , 1997, Seminars in nephrology.

[7]  H. Matsubara,et al.  Molecular insights into angiotensin II type 1 and type 2 receptors: expression, signaling and physiological function and clinical application of its antagonists. , 1998, Endocrine journal.

[8]  C. Manso,et al.  Different effects of thiol and nonthiol ace inhibitors on copper-induced lipid and protein oxidative modification. , 1996, Free radical biology & medicine.

[9]  D. Purdie,et al.  Host genetic factors influence disease progression in chronic hepatitis C , 2000, Hepatology.

[10]  W. Hall,et al.  Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy , 1992, Annals of Internal Medicine.

[11]  T. Resink,et al.  Stimulation of autocrine platelet--derived growth factor AA-homodimer and transforming growth factor beta in vascular smooth muscle cells. , 1991, Biochemical and biophysical research communications.

[12]  Shokei Kim,et al.  Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. , 1995, The Journal of pharmacology and experimental therapeutics.

[13]  M. Rossi,et al.  Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum‐induced rat liver fibrosis , 1994, Pathology international.

[14]  S. Klahr,et al.  Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. , 1994, Kidney international.

[15]  V. N. Finelli,et al.  A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. , 1981, Analytical biochemistry.

[16]  R. Head,et al.  The effect of captopril treatment and its withdrawal on the gene expression of the renin-angiotensin system. , 1994, Blood pressure.

[17]  D. Schuppan,et al.  An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. , 2000, Gastroenterology.

[18]  P. Scheuer,et al.  Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.

[19]  S. Friedman.  Cytokines and Fibrogenesis , 1999, Seminars in liver disease.

[20]  D. Schuppan,et al.  Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats , 1997, Hepatology.

[21]  G. Gibbons,et al.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. , 1992, The Journal of clinical investigation.

[22]  M. Arthur.  Fibrosis and Altered Matrix Degradation , 1998, Digestion.

[23]  H. Sato,et al.  Dual expression of matrix metalloproteinase‐2 and membrane‐type 1‐matrix metalloproteinase in fibrotic human livers , 1997, Hepatology.

[24]  R. Bataller,et al.  Angiotensin II induces contraction and proliferation of human hepatic stellate cells. , 2000, Gastroenterology.

[25]  C. White,et al.  Pharmacologic, Pharmacokinetic, and Therapeutic Differences among ACE Inhibitors , 1998, Pharmacotherapy.

[26]  D. Rockey,et al.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. , 1996, The Journal of clinical investigation.

[27]  C. Steer,et al.  Mitochondrial membrane perturbations in cholestasis. , 2000, Journal of hepatology.

[28]  D. Sorbi,et al.  Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. , 1993, Kidney international.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[30]  T. Meyer,et al.  Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. , 1995, The Journal of clinical investigation.

[31]  D. Crawford,et al.  Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. , 1997, Journal of hepatology.

[32]  G. Davis,et al.  Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.

[33]  A. Kossakowska,et al.  Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. , 1998, The American journal of pathology.